Delays in the Diagnosis and Management of Pulmonary Arterial Hypertension: A Simulated Patient Cases Study Across Four European Countries

Background Pulmonary arterial hypertension is progressive and underdiagnosed, contributing to high morbidity and mortality. We assessed physicians’ diagnostic accuracy and management practices using simulated pulmonary arterial hypertension cases across four European countries. Methods A cross-sectional online survey (June–August 2024) enrolled 230 consultant cardiologists, pulmonologists and rheumatologists from Germany, Italy, Spain and Portugal. Each completed three simulated pulmonary arterial hypertension cases, representing idiopathic and connective tissue disease–associated presentations. Outcomes were correct diagnosis, appropriate referral and adherence to 2022 European Society of Cardiology/European Respiratory Society guideline–recommended management. Results Across all 386 cases, the correct diagnosis was made in 49% (190 of 386). Diagnostic accuracy was higher for idiopathic presentations (59%; 80 of 135) than connective tissue disease–associated presentations (44%; 110 of 251). Guideline-adherent management occurred in 33% of cases. Among those correctly diagnosing pulmonary hypertension, 32% of physicians failed to follow appropriate referral or testing pathways. Echocardiography was requested in 92% of cases (354 of 386), but pulmonary hypertension was accurately diagnosed in only 52% of those. Physicians in Portugal demonstrated significantly superior diagnostic and management accuracy compared with other countries. Less experienced physicians (2 to 10 years) achieved greater diagnostic accuracy than more experienced colleagues, particularly for idiopathic presentations. Conclusions These findings indicate persistent diagnostic and management variability across four European countries, especially for connective tissue disease–associated presentations, and suggest that enhanced echocardiographic training and clearer referral pathways could improve diagnostic accuracy and guideline-adherent care.

Authors

Institutions

Publication Details

Journal
ERJ Open Research
Published
2026-02-16
DOI
https://doi.org/10.1183/23120541.01693-2025
Primary Topic
Pulmonary Hypertension Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Delays in the Diagnosis and Management of Pulmonary Arterial Hypertension: A Simulated Patient Cases Study Across Four European Countries

Fabio Dardi, Brian McCullagh, William A. Neill, Milos Meandzija et al.
ERJ Open Research
Pulmonary Hypertension Research and Treatments
article

Delays in the Diagnosis and Management of Pulmonary Arterial Hypertension: A Simulated Patient Cases Study Across Four European Countries

Fabio Dardi, Brian McCullagh, William A. Neill, Milos Meandzija, Alejandro Cruz-Utrilla, Filipa Madureira Antunes Ferreira
article en

Abstract

Background Pulmonary arterial hypertension is progressive and underdiagnosed, contributing to high morbidity and mortality. We assessed physicians’ diagnostic accuracy and management practices using simulated pulmonary arterial hypertension cases across four European countries. Methods A cross-sectional online survey (June–August 2024) enrolled 230 consultant cardiologists, pulmonologists and rheumatologists from Germany, Italy, Spain and Portugal. Each completed three simulated pulmonary arterial hypertension cases, representing idiopathic and connective tissue disease–associated presentations. Outcomes were correct diagnosis, appropriate referral and adherence to 2022 European Society of Cardiology/European Respiratory Society guideline–recommended management. Results Across all 386 cases, the correct diagnosis was made in 49% (190 of 386). Diagnostic accuracy was higher for idiopathic presentations (59%; 80 of 135) than connective tissue disease–associated presentations (44%; 110 of 251). Guideline-adherent management occurred in 33% of cases. Among those correctly diagnosing pulmonary hypertension, 32% of physicians failed to follow appropriate referral or testing pathways. Echocardiography was requested in 92% of cases (354 of 386), but pulmonary hypertension was accurately diagnosed in only 52% of those. Physicians in Portugal demonstrated significantly superior diagnostic and management accuracy compared with other countries. Less experienced physicians (2 to 10 years) achieved greater diagnostic accuracy than more experienced colleagues, particularly for idiopathic presentations. Conclusions These findings indicate persistent diagnostic and management variability across four European countries, especially for connective tissue disease–associated presentations, and suggest that enhanced echocardiographic training and clearer referral pathways could improve diagnostic accuracy and guideline-adherent care.

ERJ Open Research
Johnson & Johnson (United States) (US), Mater Misericordiae University Hospital (IE), Adelphi Group (United Kingdom) (GB), Hospital Universitario 12 De Octubre (ES), Azienda USL di Bologna (IT), Hospital Garcia de Orta (PT)
Openalex Percentile: Top 54%
Pulmonary Hypertension Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.